Skip to main content

Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

 

  • Goldman Sachs initiated coverage on Guidewire Software Inc (NYSE: GWRE) with a Neutral rating. The price target for Guidewire Software is set to $57. Guidewire Software shares gained 0.48 percent to close at $60.27 on Monday.
  • Analysts at Macquarie initiated coverage on Royal Caribbean Cruises Ltd (NYSE: RCL) with an Outperform rating. Royal Caribbean Cruises shares gained 0.54 percent to $74.97 in pre-market trading.
  • Analysts at DA Davidson initiated coverage on Proofpoint Inc (NASDAQ: PFPT) with a Neutral rating. The price target for Proofpoint is set to $80. Proofpoint shares fell 1.82 percent to close at $73.49 on Monday.
  • Analysts at Macquarie initiated coverage of Carnival Corp (NYSE: CCL) with a Neutral rating. Carnival shares gained 0.83 percent to $49.54 in pre-market trading.
  • Analysts at Leerink Swann assumed SAGE Therapeutics Inc (NASDAQ: SAGE) with an Outperform rating. The price target for SAGE Therapeutics is set to $68. SAGE Therapeutics shares declined 0.89 percent to close at $45.64 on Monday.
  • Analysts at Argus Research initiated coverage on United Rentals, Inc. (NYSE: URI) with a Buy rating. The price target for United Rentals is set to $90. United Rentals shares rose 0.56 percent to close at $78.93 on Monday.
  • Rodman & Renshaw initiated coverage on Tecogen Inc (NASDAQ: TGEN) with a Buy rating. The price target for Tecogen is set to $6. Tecogen shares dropped 3.85 percent to close at $4.00 on Monday.
  • Analysts at DA Davidson initiated coverage on HubSpot Inc (NYSE: HUBS) with a Buy rating. The price target for HubSpot is set to $76. HubSpot shares dropped 0.03 percent to close at $57.60 on Monday.
  • Analysts Piper Jaffray initiated coverage on Xencor Inc (NASDAQ: XNCR) with an Overweight rating. Xencor shares gained 0.37 percent to close at $24.58 on Monday.
  • Brean Capital assumed Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) with a Buy rating. The price target for Alexion Pharmaceuticals is set to $221. Alexion Pharmaceuticals shares slipped 0.33 percent to close at $122.14 on Monday.

Latest Ratings for GWRE

DateFirmActionFromTo
Mar 2021CitigroupMaintainsNeutral
Mar 2021NeedhamMaintainsBuy
Dec 2020NeedhamMaintainsBuy

View More Analyst Ratings for GWRE
View the Latest Analyst Ratings

 

Related Articles (RCL + GWRE)

View Comments and Join the Discussion!

Posted-In: Top InitiationsInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
NIUDaiwa CapitalInitiates Coverage On41.5
QMCONorthland Capital MarketsInitiates Coverage On12.0
IBKRJefferiesInitiates Coverage On89.0
MRETFTD SecuritiesDowngrades18.5
SWKSGoldman SachsDowngrades135.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com